Radcliffe Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Radcliffe Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-370,982	Closed	-$3.71M	–	1159
2022 Q3	$3.71M	Buy	370,982 +1,331	+0.4%	+$13.2K	0.09%	391
2022 Q2	$3.66M	Buy	369,651 +82,635	+29%	+$816K	0.08%	415
2022 Q1	$2.83M	Buy	287,016 +87,016	+44%	+$855K	0.06%	496
2021 Q4	$1.96M	Hold	200,000	–	–	0.05%	580
2021 Q3	$1.96M	Hold	200,000	–	–	0.06%	478
2021 Q2	$1.98M	Hold	200,000	–	–	0.06%	500
2021 Q1	$2.05M	Buy	+200,000	New	+$2.22M	0.08%	412

Radcliffe Capital Management's LUXA Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 370,982 shares — an estimated $3.71M sold.

Radcliffe Capital Management first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $3.71M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Radcliffe Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 370,982 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.71M.
Radcliffe Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $3.71M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.